Progentos Therapeutics
Progentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms.
Domain
progentos.com
Country
United StatesIndustry
Life ScienceEmployees
11-50
Last Funding
$65.0M
Founded
2022
Tech Stack (11 technologies)
Frequently Asked Questions
What technologies does Progentos Therapeutics use?+
Progentos Therapeutics uses 11 technologies including Sentry, Wix, React.
What industry is Progentos Therapeutics in?+
Progentos Therapeutics operates in the Life Science industry.
Where is Progentos Therapeutics based?+
Progentos Therapeutics is headquartered in United States.
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026